BAW2881 is primarily utilized in research settings to study its effects on angiogenesis, the process of new blood vessel formation. It is known to inhibit vascular endothelial growth factor receptor (VEGFR) signaling, making it a valuable tool in understanding tumor growth and metastasis. Researchers use it to explore potential therapeutic strategies for cancer, as blocking angiogenesis can starve tumors of essential nutrients. Additionally, it is employed in preclinical studies to investigate its efficacy in treating diseases characterized by abnormal blood vessel growth, such as age-related macular degeneration. Its role in these areas highlights its significance in advancing biomedical research and drug development.